Saltar al contenido principal
Elsevier

Type 2 Diabetes and Dementia

  • 1 Edición - 9 de febrero de 2018
  • Última edición
  • Editores: Velandai Srikanth, Zoe Arvanitakis
  • Idioma: Inglés

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features,… Leer más

Descripción

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology.

Puntos claves

  • Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics
  • Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinology
  • Includes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications

De interès para

Researchers and clinical practitioners in neurology, neuroscience, geriatric medicine, and endocrinology

Índice

1. Introduction

2. Epidemiology of type 2 diabetes and dementia

3. Magnitude and trajectories of Type 2 diabetes mellitus (DM)-associated cognitive dysfunction

4. Brain Imaging in Diabetes

5. Cerebrospinal Fluid and Blood-Based Biomarkers in Alzheimer’s Disease and Type 2 Diabetes Spectrum Disorders

6. Neuropathologic insights into diabetes

7. Diet, obesity, exercise, metabolism and brain

8. The role of insulin resistance and signalling in dementia

9. Advanced Glycation, Diabetes and Dementia

10. Neuroinflammation, Type 2 Diabetes and Dementia

11. The blood-brain barrier in diabetes mellitus

12. Pharmacological and non-pharmacological interventions for cognitive impairment and dementia related to type 2 diabetes and metabolic disturbances in aging

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 11 de abril de 2018
  • Idioma: Inglés

Sobre los editores

VS

Velandai Srikanth

Dr. Srikanth is an Associate Professor in the Department of Medicine, School of Clinical Sciences at Monash Health at Monash University in Melbourne, Australia. He is also a Specialist Geriatrician in Neurosciences & Geriatric Medicine at Monash Health. He is the Head, Stroke and Ageing Research and Lead of the Vascular Brain Aging Division. Dr. Srikanth is an NHMRC Career Development & Heart Foundation Future Leader Fellow. His research focuses on the effects and mechanisms of brain aging in cohort studies, with particular reference to the interface between metabolic disease, cerebrovascular disease and neurodegeneration.
Afiliaciones y experiencia
Peninsula Health and Monash University, Melbourne, VIC, Australia

ZA

Zoe Arvanitakis

Zoe Arvanitakis is a Professor of Neurology at the Rush Memory Clinic, Armour Academic Center in Chicago, IL USA
Afiliaciones y experiencia
Professor of Neurology, Rush Memory Clinic, Armour Academic Center, Chicago, IL USA

Ver libro en ScienceDirect

Lee Type 2 Diabetes and Dementia en ScienceDirect